A detailed history of Delphi Management Inc /Ma/ transactions in Incyte Corp stock. As of the latest transaction made, Delphi Management Inc /Ma/ holds 7,416 shares of INCY stock, worth $439,175. This represents 0.46% of its overall portfolio holdings.

Number of Shares
7,416
Previous 8,783 15.56%
Holding current value
$439,175
Previous $607,000 26.03%
% of portfolio
0.46%
Previous 0.59%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 08, 2025

SELL
$60.0 - $75.26 $82,020 - $102,880
-1,367 Reduced 15.56%
7,416 $449,000
Q4 2024

Feb 10, 2025

BUY
$65.08 - $83.38 $493,501 - $632,270
7,583 Added 631.92%
8,783 $607,000
Q2 2024

Aug 23, 2024

BUY
$51.18 - $63.75 $61,416 - $76,500
1,200 New
1,200 $73,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $13.2B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Delphi Management Inc /Ma/ Portfolio

Follow Delphi Management Inc /Ma/ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Delphi Management Inc /Ma/, based on Form 13F filings with the SEC.

News

Stay updated on Delphi Management Inc /Ma/ with notifications on news.